SQSTM1 and colorectal carcinoma: In Kaplan-Meier survival analysis, there was a trend demonstrating the negative prognostic effect of decreased p62 expression solely in the subgroup of CRC with KRAS mutation (p = 0.062, log-rank test) in comparison to the CRC subgroup with wildtype KRAS (p = 0.457, log-rank test).